CITADEL ADVISORS LLC

Position in SCYX — Scynexis Inc

CIK 1423053 MIAMI, FL

Back to SCYX Full portfolio

Position in SCYX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$119,972

+$54,287 QoQ

Shares Held

130,831

+25.9% QoQ

Ownership

0.165%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#16

of 44 holders

Holding Since

Mar 2021

17 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in SCYX Over Time

Shares Held

Position Value (USD)

Derivatives in SCYX

reported options exposure · as of Mar 31, 2025

CallValue

CallShares

PutValue

$1,904

PutShares

2,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $927,090,430 across 59 Drug Manufacturers - Specialty & Generic names. SCYX ranks #47 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	360,643	$213,854,086
2	INDV	Indivior Pharmaceuticals, Inc.	3,574,044	$108,936,860
3	ELAN	Elanco Animal Health Inc	4,387,127	$104,983,948
4	ALKS	Alkermes plc.	2,241,584	$79,262,409
5	SUPN	Supernus Pharmaceuticals, Inc.	1,493,446	$77,196,223
6	ZTS	Zoetis Inc.	501,011	$59,224,510
7	VTRS	Viatris Inc	3,993,155	$53,947,523
8	KNSA	Kiniksa Pharmaceuticals International, plc	474,750	$22,859,212

All Filings in SCYX

Export CSV

41 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$119,972	130,831	+25.9%	Shares	Defined	2026-05-15
2025-12-31	$65,685	103,933	+5096.7%	Shares	Defined	2026-02-17
2025-03-31	$1,904	2,000	-97.2%	Put	Defined	2025-05-15
2025-03-31	$68,883	72,357	-26.1%	Shares	Defined	2025-05-15
2024-12-31	$118,497	97,932	+988.1%	Shares	Defined	2025-02-14
2024-12-31	$10,890	9,000	+246.2%	Call	Defined	2025-02-14
2024-09-30	$3,874	2,600	-74.8%	Put	Defined	2024-11-14
2024-09-30	$15,347	10,300	-35.2%	Call	Defined	2024-11-14
2024-06-30	$31,800	15,900	+218.0%	Call	Defined	2024-08-14
2024-06-30	$10,000	5,000	-84.9%	Put	Defined	2024-08-14
2024-06-30	$66,074	33,037	+29136.3%	Shares	Defined	2024-08-14
2023-09-30	$257	113	-98.8%	Shares	Defined	2023-11-14
2023-09-30	$21,660	9,500	+533.3%	Put	Defined	2023-11-14
2023-09-30	$3,420	1,500	-92.5%	Call	Defined	2023-11-14
2023-06-30	$58,705	19,900	+362.8%	Call	Defined	2023-08-14
2023-06-30	$12,685	4,300	-82.4%	Put	Defined	2023-08-14
2023-03-31	$73,200	24,400	-22.0%	Call	Defined	2023-05-15
2023-03-31	$93,900	31,300	-8.5%	Put	Defined	2023-05-15
2022-12-31	$53,352	34,200	+902.1%	Call	Defined	2023-02-14
2022-12-31	$5,324	3,413	-58.9%	Shares	Defined	2023-02-14
2022-12-31	$12,948	8,300	-80.7%	Put	Defined	2023-02-14
2022-09-30	$103,401	43,084	+291.7%	Shares	Defined	2022-11-14
2022-09-30	$26,400	11,000	-29.4%	Put	Defined	2022-11-14
2022-06-30	$28,965	15,573	-6.7%	Shares	Defined	2022-08-15
2022-06-30	$31,062	16,700	-67.9%	Put	Defined	2022-08-15
2022-06-30	$96,720	52,000	+291.0%	Call	Defined	2022-08-15
2022-03-31	$52,003	13,300	-60.6%	Put	Defined	2022-05-16
2022-03-31	$131,891	33,732	+62.2%	Shares	Defined	2022-05-16
2022-03-31	$81,328	20,800	+20.5%	Call	Defined	2022-05-16
2021-12-31	$105,260	17,256	-54.0%	Shares	Defined	2022-02-14
2021-12-31	$228,750	37,500	+24.6%	Put	Defined	2022-02-14
2021-12-31	$183,610	30,100	+8.7%	Call	Defined	2022-02-14
2021-09-30	$146,810	27,700	+46.6%	Put	Defined	2021-11-15
2021-09-30	$100,170	18,900	-60.1%	Call	Defined	2021-11-15
2021-09-30	$250,960	47,351	-44.2%	Shares	Defined	2021-11-15
2021-06-30	$624,864	84,900	+193.9%	Call	Defined	2021-08-16
2021-06-30	$212,586	28,884	-55.3%	Shares	Defined	2021-08-16
2021-06-30	$475,456	64,600	+19.1%	Put	Defined	2021-08-16
2021-03-31	$430,506	54,220	+261.5%	Shares	Defined	2021-05-21
2021-03-31	$119,100	15,000	-70.1%	Put	Defined	2021-05-21
2021-03-31	$397,794	50,100	—	Call	Defined	2021-05-21
No filing history on record for this holder in this stock.